N/A
Completed N=158
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Source: ClinicalTrials.gov NCT02340715 ↗Enrolled (actual)
158
Serious AEs
0.0%
Results posted
Oct 2017
Primary outcomePrimary: Number of Participants Successfully Contributing MRI Data — 158 Participants
Summary
The purpose of this study is to determine if it would be helpful to use advanced MRI imaging techniques to take additional views of the tumor target for radiation treatment planning or treatment follow-up MRI.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Successfully Contributing MRI Data |
158 | — |
Eligibility Criteria
Inclusion Criteria
- Patients aged 18 years older of any race or gender with anal canal, brain, breast, cervix, esophagus, gynecology, head and neck, lung, pancreas, primary liver or liver metastases, prostate cancer or sarcoma either undergoing MRI scan for radiation treatment planning or a post treatment MRI
- Voluntarily signs an IRB approved consent form
Exclusion Criteria
- Inability to obtain informed consent from the patient or their medical power of attorney
- Patients who are not undergoing MR for radiation treatment planning
- Patients who will not have MRI scans after treatment
- Patients with pacemakers or other non-MRI compatible metallic implants
- Pregnant women, by self report using a standard MRI questionnaire
- Patients who will not receive contrast agent as part of their standard MR, will participate only in the non-contrast portion of the study
Data sourced from ClinicalTrials.gov (NCT02340715). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.